Europe Compounding Pharmacies Market Report 2023: Sector to Grow by 8.25% Annually Through 2028 - ResearchAndMarkets.com
Retrieved on:
Monday, January 9, 2023
Health, Pharmaceutical, McKesson Corporation, United Kingdom, Oral, Omnicell, Fagron, Pain management, Pharmacy, Competition, Allergy, Patient, Growth, Strong Bad Sings (and Other Type Hits), Prevalence, Fresenius, Acquisition, European, USD, Investment, User (computing), COVID-19, Pharmaceutical industry, Lithium, Medicinal plants, Dermatology, Nordic
The European Compounding Pharmacies Market is projected to display significant growth represented by a CAGR of 8.25% during 2023-2028.
Key Points:
- The European Compounding Pharmacies Market is projected to display significant growth represented by a CAGR of 8.25% during 2023-2028.
- The European Compounding Pharmacies Market was valued at USD 3314.80 Million in the year 2021 with Italy holding the largest market share.
- The report analyses the Europe Compounding Pharmacies Market by Type (Oral, Topical, Ophthalmic, Injecs, and Others Types).
- The Europe Compounding Pharmacies Market has been analysed by Country (United Kingdom, Germany, France, Italy, Spain, Russia, Turkey, Benelux, Nordic, and Rest of Europe).